德國Fresenius Biotech
費森尤斯生物技術:生物制藥產品的開發及銷售,主要應用于基因、腫瘤、移植和再生醫學領域。
Fresenius Biotech is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. A focal point of our activities is the development of immunotherapeutic products based on innovative antibody technologies. Our focused approach to research and development combined with our international marketing experience enables us to efficiently bring targeted therapeutics to a global patient population.
Our main areas of research:
Transplantation
Oncology
Our core competencies:
Preclinical research and clinical development
Worldwide registration of biopharmaceuticals
Innovative marketing for specialized indications
Attaining market access for innovative products
Founded in 2003, Fresenius Biotech employs approx. 170 employees in Europe and the USA. Fresenius Biotech is a subsidiary of the Fresenius SE healthcare group.